Lawtons Drugs

lawtons.ca

As a parent company and a strong supporter of Lawtons Drugs, Sobeys core values reflect the commitment and convictions that have helped shape the company over the past 100 years. Since our 1907 beginning as a small pharmacy in Newfoundland, Lawtons Drugs has portrayed integrity, commitment to its employees, and a desire to consistently exceed customer expectations in service, value and product selection. Lawtons Drugs has since grown to 80 locations in Atlantic Canada with plans to expand even further. Our pharmacy services complement customers’ prescriptions and help them manage their family’s medication and health care needs. Lawtons Drugs has a full line of home healthcare solutions, beauty, cosmetics, convenience and giftware products to suit everyone’s needs.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Pharmacy Market

NOVARTIS' SANDOZ SPOTLIGHTS IMPORTANCE OF GENERIC DRUGS IN NEW SOCIAL CAMPAIGN

Novartis | December 17, 2020

news image

Did you realize that 90% of remedies are composed for nonexclusive medications? Novartis' Sandoz is getting the news out about nonexclusive medication with such realities in its as of late dispatched "Request Generics" crusade. It's Sandoz's first significant instruction and mindfulness crusade via online media to advance the estimation of generics. The intended interest group is key partners—patients, clinicians, policymakers and payers—with mess...

Read More

Business Insights, VIEWS AND ANALYSIS

RANCHO BIOSCIENCES WELCOMES BENEVOLENTAI AS FIFTH MEMBER OF SCDS CONSORTIUM

Rancho BioSciences | February 02, 2023

news image

On February 1, 2023, Rancho Biosciences, a leading provider of data sciences services, announced that BenevolentAI has joined the SCDS consortium as its fifth member. Rancho Biosciences launched its Single Cell Data Science (SCDS) pre-competitive consortium on February 26, 2022, with four Charter Members: Bristol Myers Squibb, Janssen Research & Development LLC, a subsidiary of Johnson & Johnson's Janssen Pharmaceutical Companies, Novartis, and Vesalius Therapeutics. ...

Read More

Business Insights

ILLUCCIX® AVAILABLE ON HIGH ACTIVITY GALLIUM GENERATOR TECHNOLOGY TO MEET HIGH DEMAND

Telix Pharmaceuticals Limited | November 23, 2022

news image

Telix Pharmaceuticals Limited announces Illuccix® with up to 50mCi for radiolabeling is available for use on 100mCi gallium generators, an important development in radioisotope production. High activity generators from Eckert & Ziegler Strahlen- und Medizintechnik AG increase activity from 50mCi to 100mCi and will be integral to expanding patient access to gallium-based radiopharmaceuticals as demand for PSMA-PET imaging in the United States continues to grow. This technol...

Read More

Pharmacy Market

VIRPAX PHARMACEUTICALS RECAPS MILESTONES AND HIGHLIGHTS PRODUCT PORTFOLIO

Virpax® Pharmaceuticals, Inc. | December 29, 2021

news image

Virpax® Pharmaceuticals, Inc. "Company" achieved significant milestones relating to its pipeline of product candidates as of the end of 2021, which are summarized below. “I believe that Virpax has made significant progress this past year toward our stated goalsThese accomplishments include accelerated development of our existing product candidates, broadening our pipeline of product candidates, and utilizing grants where appropriate. We recently...

Read More
news image

Pharmacy Market

NOVARTIS' SANDOZ SPOTLIGHTS IMPORTANCE OF GENERIC DRUGS IN NEW SOCIAL CAMPAIGN

Novartis | December 17, 2020

Did you realize that 90% of remedies are composed for nonexclusive medications? Novartis' Sandoz is getting the news out about nonexclusive medication with such realities in its as of late dispatched "Request Generics" crusade. It's Sandoz's first significant instruction and mindfulness crusade via online media to advance the estimation of generics. The intended interest group is key partners—patients, clinicians, policymakers and payers—with mess...

Read More
news image

Business Insights, VIEWS AND ANALYSIS

RANCHO BIOSCIENCES WELCOMES BENEVOLENTAI AS FIFTH MEMBER OF SCDS CONSORTIUM

Rancho BioSciences | February 02, 2023

On February 1, 2023, Rancho Biosciences, a leading provider of data sciences services, announced that BenevolentAI has joined the SCDS consortium as its fifth member. Rancho Biosciences launched its Single Cell Data Science (SCDS) pre-competitive consortium on February 26, 2022, with four Charter Members: Bristol Myers Squibb, Janssen Research & Development LLC, a subsidiary of Johnson & Johnson's Janssen Pharmaceutical Companies, Novartis, and Vesalius Therapeutics. ...

Read More
news image

Business Insights

ILLUCCIX® AVAILABLE ON HIGH ACTIVITY GALLIUM GENERATOR TECHNOLOGY TO MEET HIGH DEMAND

Telix Pharmaceuticals Limited | November 23, 2022

Telix Pharmaceuticals Limited announces Illuccix® with up to 50mCi for radiolabeling is available for use on 100mCi gallium generators, an important development in radioisotope production. High activity generators from Eckert & Ziegler Strahlen- und Medizintechnik AG increase activity from 50mCi to 100mCi and will be integral to expanding patient access to gallium-based radiopharmaceuticals as demand for PSMA-PET imaging in the United States continues to grow. This technol...

Read More
news image

Pharmacy Market

VIRPAX PHARMACEUTICALS RECAPS MILESTONES AND HIGHLIGHTS PRODUCT PORTFOLIO

Virpax® Pharmaceuticals, Inc. | December 29, 2021

Virpax® Pharmaceuticals, Inc. "Company" achieved significant milestones relating to its pipeline of product candidates as of the end of 2021, which are summarized below. “I believe that Virpax has made significant progress this past year toward our stated goalsThese accomplishments include accelerated development of our existing product candidates, broadening our pipeline of product candidates, and utilizing grants where appropriate. We recently...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us